Discover why AbbVie (ABBV) is rated Strong Buy, with robust 2025 growth, diversified revenues, and attractive valuation.

In follow up to the August 4, 2025 guidance and September 26, 2025 In re Desjardins decision, the USPTO recently took another significant step ...

Artificial intelligence patenting in insurance is becoming a high-stakes, highly concentrated race dominated by a handful of U.S. carriers.

Every year has its “it” term.In 2025, the crown belonged to AI, and rightfully so. AI dominated the headlines, flooded the USPTO’s dockets, ...

Mindpeak, a global pioneer in AI-powered pathology solutions, is today thrilled to announce that it has been granted its first patent, covering a groundbreaking novel way to train an AI system so it ...

India - Flawed Claim Mapping Can Lead To Lost Infringement Battle. Legal News and Analysis - India - Intellectual Property - Conventus Law ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Industry experts ...

Engines have remained fairly true to form over the years without a lot of unusual changes, but a new Ferrari design could ...

Below, CNBC Select explains the differences between trademarks, copyrights and patents. Read on for more information and to ...

In complaints filed in multiple arenas on Tuesday, Bobcat Company alleges Caterpillar Inc. has infringed on multiple patents ...

When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...

Perplexity AI has launched Perplexity Patents, an AI-powered tool that streamlines patent search and analysis. Unveiled by CEO Aravind Srinivas, the platform — billed as the “world’s first AI patent ...